Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial

Matthew C. Choy, C Li Wai Suen, Danny Con, Kristy Boyd, Raquel Peña, Kathryn Burrell, Ourania Rosella, David Proud, Richard Brouwer, Alexandra Gorelik, Danny Liew, William Connell, Emily K. Wright, Kirstin M. Taylor, Aviv Pudipeddi, Michelle Sawers, Britt Christensen, Watson Ng, Jakob Begun, Graham Radford‐Smith, Mayur Garg, Neal Martin, Daniel R. van Langenberg, Nik S. Ding, Lauren Beswick, Rupert W. Leong, Miles Sparrow, Peter De Cruz